World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Reds under our meds
Keywords:
The Economist quotes experts saying that drug innovations would not be affected by price controls on drugs. Pricing reforms can accomplish the reverse, spur innovation by doing as Britain and Germany are doing- pioneering comparitive reviews of drugs effectiveness and cost-benefit analyses aimed at reimbursing firms for new drugs based on their performance. Sanford Bernstein, a financial advisory firm, says in its study that a 20% reduction in what Medicare pays for drugs would not kill off innovation, it would reduce earnings per share of big pharma firms by 3-8%. As drug research is now done in many countries, and its a globalized industry, innovation is not likely to be automatically affected by price reductions in one country like the USA, according to Alna Garber of Stanford University and Patricia Danzon of Wharton Business School.
Medical clinics at drugstores and retail locations offer convenience and lower price to meet a growing need.
03/05/2009
In some locations over a third of patients at these clinics ar the uninsured. About 1 in 10 are affiliated with hospitals . Even the Cleveland Clinic and the Mayo Clinic are joining this trend, and Mayo Clinic doctors think the primary care physicians offices can learn from this and help this trend.
Grouped Articles
Drug Ruling Puts Devices in Spotlight
New York Times 03/05/2009
Health-Care Battle Set to Focus on Public Plan
Wall Street Journal 03/24/2009
Hospitals Begin to Move Into Supermarkets
New York Times 05/12/2009
Wal-Mart Begins to Rebuild Health Clinic Business
New York Times 05/12/2009
Economist 08/27/2009
Safeway Shifts Tactics in Grocery Price War
Wall Street Journal 10/16/2009
Meeting the cost concerns of governments and insurers. Efforts by pharmaceutical companies.
11/09/2006
Efforts by companies like GlaxoSMithKline to meet cost concerns of governments by linking pricing to the effectiveness of the drugs or treatments. Pharmaceutical pricing an issue with governments.
Grouped Articles
Wall Street Journal 11/09/2006
Glaxo Chief Charts New Growth Strategy
Wall Street Journal 06/10/2008
Pricey Drugs Put Squeeze on Doctors
Wall Street Journal 07/08/2008
Drug Makers Trim Prices for Health Overhaul
Wall Street Journal 06/22/2009
For Drug Makers, Concessions Have a Bright Side
Wall Street Journal 06/23/2009
New York Times 06/25/2009
The French health care system and its costs, comparison with the American system of health care.
06/28/2007
The rising costs of the French system and its concept and performance. Efforts to meet rising costs and rise of the "mutuals." Healthcare in France is at about 11% of GNP compared to 16% in the USA, with 50 million uninsured in the US and 99% of 64 million people of France covered. Pricing of pharmaceutical products and healthcare services remains a major unsolved problem in the U.S.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
New York Times 12/21/2013
The French Lesson in Health Care
BusinessWeek 06/28/2007
New York Times 07/14/2007
In Holland, Some See Model For U.S. Health-Care System
Wall Street Journal 09/06/2007
Maker of Lipitor Digs In to Fight Generic Rival
New York Times 11/03/2007
Escalating cost of Medicare with a rising deficit in the U.S.
06/15/2009
Grouped Articles
Bayonne Medical Center Has Highest U.S. Billing Rates
New York Times 05/16/2013
Doctors Chafe As Medicare Cuts Loom
Wall Street Journal 06/16/2010
Small Group of Doctors Are Biggest Medicare Billers
Wall Street Journal 06/01/2015
BusinessWeek 12/10/2009
10 Ways to Cut Health-Care Costs Right Now
BusinessWeek 11/12/2009
Preventing the Next Financial Crisis
Wall Street Journal 10/23/2009
Western pharmaceutical company growth strategies.
07/09/2007
As sales growth slows in developed countries, pricing drops, and drug development is weak, the search for new avenues for growth.
Grouped Articles
Glaxo's Garnier Is Taking the Heat
Wall Street Journal 07/09/2007
Glaxo to Weigh Results Of New Diet Pill
Wall Street Journal 10/24/2007
Prescription-Drug Sales Growth Is Expected to Slow
Wall Street Journal 11/01/2007
BusinessWeek 12/05/2007
Osteoporosis Drug Is Amgen's Hope For a Strong Future
Wall Street Journal 12/14/2007
Glaxo Becomes Master of Reinventing Drugs
Wall Street Journal 04/17/2008
Innovation and the pricing of drugs in the U.S. by the pharmaceutical companies.
06/09/2007
Will drug innovation be affected adversely by price reductions in the USA? No say experts as it is a globalized industry and innovation takes place in labs around the world. And the pricing reforms, as in Britian and Germany, can actually encourage R&D for effective drugs with good cost relationships; when comparitive effectiveness of drugs and cost benefit analyses is used in pricing reforms. Pricing of pharmaceutical products and healthcare services is the major unsolved problem in the U.S.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12/16/2013
New York Times 12/21/2013
FDA Approves Cholesterol Drug From Regeneron, Sanofi
Wall Street Journal 07/25/2015
Washington Post 09/22/2015
Settlement May Cut Drug Prices
Wall Street Journal 06/09/2007
Pharmaceutical company pricing in the U.S. and Europe
11/09/2007
The pricing of pharmaceutical products and healthcare services in the U.S. and Europe.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
India Prepares EU Trade Complaint
Wall Street Journal 08/06/2009
Democrats Say No to Cost Cap for Drug Makers
New York Times 08/07/2009
Economist 08/27/2009
Large Price Jumps Reported for Small but Vital Drugs
New York Times 01/11/2010
Financial Outlook for Medicare in the U.S.
05/13/2009
Medicare is heading for insolvency by 2037.
Grouped Articles
Home Care Yields Medicare Bounty
Wall Street Journal 04/27/2010
Toward a Different Fiscal Future
Wall Street Journal 02/08/2010
Preventing the Next Financial Crisis
Wall Street Journal 10/23/2009
Economist 10/15/2009
Economist 08/27/2009
Obama’s Pledge to Tax Only the Rich Can’t Pay for Everything, Analysts Say
New York Times 08/01/2009
Expert opinion on Medicare reform.
06/14/2009
Grouped Articles
Small Group of Doctors Are Biggest Medicare Billers
Wall Street Journal 06/01/2015
Martin Feldstein - Obama's Health-Care Reform Plan Is Not the Answer
Washington Post 07/28/2009
New York Times 07/31/2009
Obama’s Pledge to Tax Only the Rich Can’t Pay for Everything, Analysts Say
New York Times 08/01/2009
Economist 08/27/2009
Economist 10/15/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
